Patients’ acceptance of outcome and experience measurements during hospitalisation for COPD exacerbations: a CICERO Clinical Research Collaboration–European Lung Foundation online patient survey
-
Published:2023-05-11
Issue:4
Volume:9
Page:00148-2023
-
ISSN:2312-0541
-
Container-title:ERJ Open Research
-
language:en
-
Short-container-title:ERJ Open Res
Author:
Gyselinck IweinORCID, Ramakrishnan SanjayORCID, Vermeersch Kristina, Halner Andreas, Pott Hendrik, Dobbels Fabienne, Coleman Courtney, Collis Philip, Watz Henrik, Greulich Timm, Franssen Frits M.E., Burgel Pierre-RégisORCID, Bafadhel MonaORCID, Janssens WimORCID, Bafadhel Mona, Janssens Wim, Burgel Pierre-Régis, Contoli Marco, Franssen Frits, Greening Neil, Greulich Timm, Huerta Garcia Arturo, Quint Jennifer, Schmeck Bernd, Vanfleteren Lowie, Watz Henrik, Ramakrishnan Sanjay, Gyselinck Iwein, Halner Andreas, McAuley Hamish, Vermeersch Kristina, Beersaerts Amber, Abdo Mustafa, Pott Hendrik, Steven Cass, Albert Richard, Jenkins Christine, Vogelmeier Claus, Collis Philip, Bolsman Hilma, Roche , ,
Abstract
BackgroundThe lack of standardised outcome assessments during hospitalisation and follow-up for acute COPD exacerbations has hampered scientific progress and clinical proficiency. The objective of the present study was to evaluate patients’ acceptance of selected outcome and experience measurements during hospitalisations for COPD exacerbations and follow-up.MethodsAn online survey was held amongst COPD patients in France, Belgium, The Netherlands, Germany and the UK. The European Lung Foundation COPD Patient Advisory Group was involved in the conceptualisation, development and dissemination of the survey. The survey was complementary to a previously obtained expert consensus. We assessed patients’ views and acceptance of selected patient-reported outcomes or experiences and corresponding measurement instruments (for dyspnoea, frequent productive cough, health status and hospitalisation experience), and of selected clinical investigations (blood draw, pulmonary function test, 6-min walk test, chest computed tomography, echocardiography).Findings200 patients completed the survey. All selected outcomes and experiences were deemed important, and acceptance of their methods of assessment was high. The modified Medical Research Council scale and a numerical rating scale to address dyspnoea, the COPD Assessment Test for quality of life and frequent productive cough, and the Hospital Consumer Assessment of Healthcare Providers and Systems for hospital experiences were the instruments preferred by patients. Consensus on importance of blood draw and spirometry was higher compared with the other investigations.InterpretationThe survey results endorse the use of the selected outcome and experience measurements during hospitalisations for COPD exacerbations. They can be used to optimise standardised and patient-centred care and facilitate multicentric data collection.
Publisher
European Respiratory Society (ERS)
Subject
Pulmonary and Respiratory Medicine
Reference28 articles.
1. World Health Organization . Global Health Estimates: The top 10 causes of death. 2019. www.who.int/news-room/fact-sheets/detail/the-top-10-causes-of-death Date last updated: 9 December 2020. Date last accessed: 2 June 2022. 2. Economic burden of chronic obstructive pulmonary disease (COPD): a systematic literature review;Iheanacho;Int J COPD,2020 3. Royal College of Physicians . National Astha and Chronic Obstructive Pulmonary Disease Audit Programme (NACAP): COPD clinical audit 2018/19. 2020. www.nacap.org.uk/nacap/welcome.nsf/vwFiles/NACAP-COPD-SC-202007/$File/NACAP_COPD_SC_Clinical_National_Report_2018_19_060720.pdf?openelement 4. Acute exacerbations of chronic obstructive pulmonary disease: in search of diagnostic biomarkers and treatable traits 5. The CICERO (Collaboration In COPD ExaceRbatiOns) clinical research collaboration;Janssens;Eur Respir J,2020
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
|
|